$ACOR ACORDA THERAPEUTICS INC Insider Trading
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACORDA THERAPEUTICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ACORDA THERAPEUTICS INC for free.
CIK Number: 0001008848
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ACOR
Company Address: 420 SAW MILL RIVER ROAD ARDSLEY 10502
Market Capitalization: $941.09M
Prev close: $21.20
Average Daily Volume: 596,379
Days Low: $19.95
Year Low: $16.40
Year High: $37.36
ACORDA THERAPEUTICS INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 04 2021 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 3.75 | 10,000 | 37,500 | 10,000 | |
Jun 04 2021 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 3.75 | 10,000 | 37,500 | 10,000 | |
Mar 05 2021 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Grant | A | 0.00 | 11,125 | 0 | 13,732 | 2.6 K to 13.7 K (+426.74 %) |
Mar 05 2021 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 29,000 | 0 | 135,830 | 106.8 K to 135.8 K (+27.15 %) |
Mar 05 2021 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | CMO and Head of R&D | Grant | A | 0.00 | 11,125 | 0 | 18,527 | 7.4 K to 18.5 K (+150.30 %) |
Nov 12 2020 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Payment of Exercise | F | 0.86 | 1,024 | 881 | 14,952 | 16 K to 15 K (-6.41 %) |
Sep 21 2020 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Grant | A | 0.00 | 3,015 | 0 | 15,639 | 12.6 K to 15.6 K (+23.88 %) |
Sep 21 2020 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Grant | A | 0.00 | 3,015 | 0 | 15,976 | 13 K to 16 K (+23.26 %) |
Sep 21 2020 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 8,543 | 0 | 640,980 | 632.4 K to 641 K (+1.35 %) |
Sep 21 2020 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | CMO and Head of R&D | Grant | A | 0.00 | 3,015 | 0 | 44,410 | 41.4 K to 44.4 K (+7.28 %) |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | STRADER CATHERINE D. | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 |